The Discounted Cash Flow (DCF) valuation of Dr Sulaiman Al-Habib Medical Services Group Co (4013.SR) is 140.38 SAR. With the latest stock price at 262.00 SAR, the upside of Dr Sulaiman Al-Habib Medical Services Group Co based on DCF is -46.4%.
Based on the latest price of 262.00 SAR and our DCF valuation, Dr Sulaiman Al-Habib Medical Services Group Co (4013.SR) is a sell. selling 4013.SR stocks now will result in a potential gain of 46.4%.
| Range | Selected | |
| WACC / Discount Rate | 11.3% - 13.4% | 12.4% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 113.95 - 182.54 | 140.38 |
| Upside | -56.5% - -30.3% | -46.4% |